Versameb appoints world leading experts in urology to Advisory Board
- Appointment of experts to support development of lead candidate VMB-100, an RNA-based therapy for Stress Urinary Incontinence
Versameb AG (“Versameb”), focused on discovering and developing innovative RNA-based drugs, today announces the formation of an Advisory Board comprised of industry leaders in urology. These include Professor Roger Dmochowski of Vanderbilt University, Professor Margot Damaser of the Cleveland Clinic Lerner College of Medicine, and Assistant Professor Frédéric Birkhäuser of St. Anna and Hirslanden Clinic Lucerne.
